Skip to content

The Ayurvedic mangement of dysfunctional uterine bleeding by ayurvedic formulation of nalikeraprasunadi kashaya

Randomised controlled clinical study to evaluate the effect of Narikelaprasunadi kashaya over the tranexamic acid in the management of asrigdara w.s.r. to dysfunctional uterine bleeding - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104467
Enrollment
40
Registered
2026-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Sponsors

Dr Sheetal Mange
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENT FULFILLING THE DIAGNOSTIC CRITERIA BOTH MARRIED AND UNMARRIED WOMEN BETWEEN AGE GROUP OF 16-50 YEARS PATIENT WITH HB GREATER THAN 8MG PER DL

Exclusion criteria

Exclusion criteria: POST MENOPAUSAL BLEEDING PATIENT WITH IUCD AND ON OCPS PATIENT WITH SYSTEMIC DISEASES LIKE HTN,DM,PCOS,STD AND ENDOCRINE DISORDERS LIKE THYROID DISORDERS AND LIVER DISORDERS BLEEDING DUE TO ABORTIONS,POLYP,CERVICAL EROSION,UTERINE FIBROID,PID,BENIGN AND MALIGNANT GROWTH IN THE UTERUS

Design outcomes

Primary

MeasureTime frame
Menstrual bleeding will be regulariseTimepoint: 2 weeks

Secondary

MeasureTime frame
HELPS TO REGULARISE THE MENSTRUAL CYCLE,RESOLVES VOMITTING AND STRENTHENS THE GARBHASHAYATimepoint: 90 DAYS

Countries

India

Contacts

Public ContactDr Sreeja V

shree jagadguru gavisiddheshwara ayurvedic medical college koppal

dr.sreejaarun@gmail.com8971432678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026